PE Monahan, RJ Samulski… - US Patent 7,923,436, 2011 - Google Patents Illllllllllllllllllllllllllllllllllllllllllllllllll US007923436B2 (12) United States Patent Monahan et al. (io) Patent No.: (45) Date of Patent: US 7,923,436 B2 *Apr. 12, 2011 (54) METHODS AND COMPOUNDS FOR CONTROLLED RELEASE OF RECOMBINANT PARVOVIRUS VECTORS (75) ... Related articles - All 3 versions
T Carraca, A Matias, O Brandão… - Fetal Diagnosis and …, 2011 - content.karger.com Parvovirus B19 is a small single-stranded DNA virus and a potent inhibitor of erythropoiesis due to its cytotoxicity to erythroid progenitor cells. Although adult disease is generally mild, fetal parvovirus B19 infection can cause spontaneous abortion in early pregnancy and aplastic anemia, ... Related articles - All 2 versions
[HTML] from cdc.govA Lahtinen, P Kivelä, L Hedman, A Kumar… - Emerging infectious …, 2011 - cdc.gov A new member of family Parvoviridae, human parvovirus 4 (PARV4), was identified in plasma of an injection drug user (IDU) with unexplained fatigue, headaches, fever, night sweats, nausea, and diarrhea (1). In PCR studies of blood and postmortem tissues, virus was ... Cited by 2 - Related articles - Cached - All 9 versions
T Opriessnig, HG Shen, N Pal… - Clinical and Vaccine …, 2011 - Am Soc Microbiol The live chimeric porcine circovirus type 2 (PCV2) vaccine with the capsid gene of the emerging subtype 2b cloned in the genomic backbone of the nonpathogenic PCV1 is attenuated in vivo and induces protective immunity against PCV2. To further determine the safety and ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
